Premium
Combination chemotherapy of advanced Hodgkin's disease. A review
Author(s) -
Goldsmith Michael A.,
Carter Stephen K.
Publication year - 1974
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/1097-0142(197401)33:1<1::aid-cncr2820330102>3.0.co;2-t
Subject(s) - procarbazine , medicine , vincristine , prednisone , disease , chemotherapy , oncology , regimen , combination chemotherapy , nitrogen mustard , induction chemotherapy , cyclophosphamide
Clinical experience with the combination chemotherapy of Hodgkin's disease is reviewed. The results of the MOPP (nitrogen mustard, vincristine, Procarbazine, prednisone) regimen are analyzed and the various published and ongoing individual and cooperative group chemotherapy protocols for induction and maintenance in advanced Hodgkin's disease are discussed. While several new regimens are currently under investigation, at this time the MOPP program is still the treatment of choice for far‐advanced Hodgkin's disease.